reports
Veeva Systems Inc: 1 director
A director at Veeva Systems Inc sold 3,882 shares at 216.830USD and the significance rating of the trade was 80/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
TowerBrook and CD&R Complete Acquisition of R1 RCM
TowerBrook and CD&R Complete Acquisition of R1 RCM R1 RCM Becomes Privately Held Company; Joe Flanagan Reappointed as CEO MURRAY, Utah, Nov. 19, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (“R1”), a leader in automating revenue management for healthcare providers, today announced that investment funds affiliated with TowerBrook Capital Partners (“TowerBrook”) and Clayton, Dubilier & Rice (“CD&R”) have completed their previously announced acquisition of R1. On August 1, 2024, TowerBrook, CD&R and R1 announced that they had entered into a definitive merger agreement under which all outstanding ...
R1 RCM Reports Third Quarter 2024 Results
R1 RCM Reports Third Quarter 2024 Results MURRAY, Utah, Nov. 05, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended September 30, 2024. Third Quarter 2024 Results: Revenue of $656.8 million, up $84.0 million or 14.7% compared to the same period last year.GAAP net loss of $19.9 million, compared to net income of $1.3 million in the same period last year.Adjusted EBITDA of $148...
R1 RCM Reports Second Quarter 2024 Results
R1 RCM Reports Second Quarter 2024 Results MURRAY, Utah, Aug. 07, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended June 30, 2024. Second Quarter 2024 Results: Revenue of $627.9 million, up $67.2 million or 12.0% compared to the same period last year.GAAP net loss of $7.6 million, compared to net loss of $1.0 million in the same period las...
R1 RCM to be Acquired by TowerBrook and CD&R for $8.9 Billion
R1 RCM to be Acquired by TowerBrook and CD&R for $8.9 Billion Stockholders to Receive $14.30 Per Share in Cash MURRAY, Utah, Aug. 01, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that it has entered into a definitive agreement to be acquired by investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice (“CD&R”), in an all-cash transaction with an enterprise value of approxi...
R1 RCM Special Committee Provides Update on Evaluation of Strategic Al...
R1 RCM Special Committee Provides Update on Evaluation of Strategic Alternatives Sets Final Bid Deadline of July 31, 2024 MURRAY, Utah, July 24, 2024 (GLOBE NEWSWIRE) -- The Special Committee of the R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”) Board of Directors, which comprises independent directors and was formed to evaluate strategic alternatives in response to the Schedule 13D/A filed by New Mountain Capital, L.L.C. (“New Mountain Capital”) with the Securities and Exchange Commission on February 26, 2024, today announced it has set a final deadline for interested parties to sub...
R1 RCM to Release Second Quarter 2024 Results on August 7, 2024
R1 RCM to Release Second Quarter 2024 Results on August 7, 2024 MURRAY, Utah, July 15, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended June 30, 2024, before market open on Wednesday, August 7, 2024 and host a conference call at 8:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 888-596-4...
R1 RCM to Host a Virtual Event “Technology Teach-In: A Deep Dive into ...
R1 RCM to Host a Virtual Event “Technology Teach-In: A Deep Dive into Key Focus Areas and the R1 Platform” on June 27, 2024 MURRAY, Utah, June 17, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it will host a virtual event on Thursday, June 27, 2024 at 11:00 AM ET. To register, . The event will feature Steve Albert, Executive Vice President and Chief Product Officer, and Brian Gambs, Executive Vice Presiden...
R1 RCM to Present at the 2024 Jefferies Global Healthcare Conference
R1 RCM to Present at the 2024 Jefferies Global Healthcare Conference MURRAY, Utah, May 24, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at the 2024 Jefferies Global Healthcare Conference on Wednesday, June 5, 2024, at 10:30am ET. A live audio webcast of this presentation will be available on the Investor Relations section of R1’s website at . A replay of the webcast will be available for 90 days ...
R1 RCM Reports First Quarter 2024 Results
R1 RCM Reports First Quarter 2024 Results MURRAY, Utah, May 08, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups, today announced results for the three months ended March 31, 2024 and updated full year 2024 outlook. First Quarter 2024 Results: Revenue of $603.9 million, up $58.3 million or 10.7% compared to the same period last year.GAAP net loss...
R1 RCM to Present at the 2024 Bank of America Securities Health Care C...
R1 RCM to Present at the 2024 Bank of America Securities Health Care Conference MURRAY, Utah, April 30, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at the 2024 Bank of America Securities Health Care Conference on Thursday, May 16, 2024, at 11:00am ET. A live audio webcast of this presentation will be available on the Investor Relations section of R1’s website at . A replay of the webcast will be...
R1 RCM to Release First Quarter 2024 Results on May 8, 2024
R1 RCM to Release First Quarter 2024 Results on May 8, 2024 MURRAY, Utah, April 01, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended March 31, 2024, before market open on Wednesday, May 8, 2024 and host a conference call at 8:00 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 888-596-4144...
R1 Releases Fourth Annual Environmental, Social and Governance (ESG) R...
R1 Releases Fourth Annual Environmental, Social and Governance (ESG) Report Report highlights R1’s commitment to corporate responsibility and sustainability across the company’s global footprint MURRAY, Utah, March 27, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, has released its . The report details the company’s commitment to improving access to healthcare, bringing responsible global citizenship to life through its ESG program. R1 meets health...
R1 RCM Forms Special Committee to Evaluate Strategic Alternatives
R1 RCM Forms Special Committee to Evaluate Strategic Alternatives MURRAY, Utah, March 11, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced the formation of a special committee comprised solely of independent directors (the “Special Committee”) to evaluate strategic alternatives in response to the Schedule 13D/A filed by New Mountain Capital, L.L.C. (“New Mountain Capital”) with the Securities and Exchange Comm...
R1 RCM Reports Fourth Quarter and Full Year 2023 Results
R1 RCM Reports Fourth Quarter and Full Year 2023 Results MURRAY, Utah, Feb. 27, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups, today announced results for the three months and year ended December 31, 2023. Fourth Quarter 2023 Results: Revenue of $575.1 million, up $41.8 million or 7.8% compared to the same period last yearGAAP net income of $1.4 million, compared to a net loss of $36.6 million ...
R1 RCM to Present at Upcoming Investor Conferences
R1 RCM to Present at Upcoming Investor Conferences MURRAY, Utah, Feb. 16, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at two upcoming conferences: The 2024 TD Cowen Healthcare Conference on Monday, March 4 at 10:30am ETThe 2024 Barclays Global Healthcare Conference on Wednesday, March 13 at 4:35pm ET A live audio webcast of each presentation will be available on the Investor Relations section o...
R1 Wins Multiple Best in KLAS Awards for Third Straight Year
R1 Wins Multiple Best in KLAS Awards for Third Straight Year Top ranking for Ambulatory RCM Services, Government Reimbursement Services, and Underpayment Recovery Services underscores domain expertise and technology capabilities MURRAY, Utah, Feb. 07, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that it was ranked number one in three Best in KLAS categories for 2024, including a fourth consecutive award in the Ambulatory RCM Servic...
R1 RCM Completes Acquisition of Acclara, Providence’s Modular Services...
R1 RCM Completes Acquisition of Acclara, Providence’s Modular Services Business Company Enters 10-Year Agreement to Provide Comprehensive Revenue Cycle Management Services to Providence Company to Release Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Outlook on February 27, 2024 MURRAY, Utah, Jan. 17, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that it has completed its previously announced acquisition of ...
R1 RCM Announces Preliminary Fourth Quarter Results
R1 RCM Announces Preliminary Fourth Quarter Results R1 RCM expects fourth quarter revenue of approximately $563 to $567 million, GAAP Operating income of $36 to $39 million, GAAP net loss of $8 to $10 million and adjusted EBITDA of $163 to $166 millionCompany to provide details on its 2024 outlook in conjunction with reporting 2023 results in February 2024 MURRAY, Utah, Jan. 08, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced prelimina...
R1 RCM to Present at the 42nd Annual J.P. Morgan Healthcare Conference
R1 RCM to Present at the 42nd Annual J.P. Morgan Healthcare Conference MURRAY, Utah, Dec. 21, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2023, at 10:30am ET. A live audio webcast of each presentation will be available on the Investor Relations section of R1’s website at . A replay of the webcast will be available for 90...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.